SEC Tracker
Get the app

Xtant Medical Holdings XTNT

The Company was party to an Investor Rights Agreement with ROS Acquisition and ORO II

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Ends a material agreement (1.02)
  • Reports quarterly results (2.02)
  • Reports a change in control (5.01)
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Xtant Medical Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Hyperfine HYPR public float $44M, Jun 30, 2025
  2. Vivani Medical EYES public float $46M, Jun 30, 2025
  3. Vivos RDGL public float $48M, Jun 30, 2025
  4. Alpha Pro Tech APT public float $41M, Jun 30, 2025
  5. Nuo Therapeutics AURX public float $41M, Jun 30, 2025